China Reform (China) Top Management

000503 Stock   13.01  0.24  1.88%   
China Reform employs about 1.4 K people. The company is managed by 11 executives with a total tenure of roughly 3314 years, averaging almost 301.0 years of service per executive, having 129.09 employees per reported executive. Analysis of China Reform's management performance can provide insight into the company performance.
Wei Han  President
President
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Reform Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

China Reform Management Team Effectiveness

The company has return on total asset (ROA) of (0.0499) % which means that it has lost $0.0499 on every $100 spent on assets. This is way below average. China Reform's management efficiency ratios could be used to measure how well China Reform manages its routine affairs as well as how well it operates its assets and liabilities. At present, China Reform's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 546.7 M, whereas Total Assets are forecasted to decline to about 1.4 B.
As of March 17, 2025, Common Stock Shares Outstanding is expected to decline to about 1 B. The current year's Net Loss is expected to grow to about (72.2 M)

China Reform Workforce Comparison

China Reform Health is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 63,116. China Reform holds roughly 1,420 in number of employees claiming about 2.25% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.5) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.5.

China Reform Health Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. China Reform Health Price Series Summation is a cross summation of China Reform price series and its benchmark/peer.

China Reform Notable Stakeholders

A China Reform stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as China Reform often face trade-offs trying to please all of them. China Reform's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting China Reform's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Wei HanPresidentProfile
Yingjie LiuDeputy DirectorProfile
Dicao SunDeputy DirectorProfile
Zhongsheng WangGeneral OfficerProfile
Yonghua LiNonIndependent MangProfile
Qin XiaoS BoardProfile
Hongquan YuanGeneral ManagerProfile
Liqun SunDeputy ManagerProfile
Wenchang WangChief AccountantProfile
Xuetang HuangFinancial MangProfile
Xinxing LiuBoard SecretaryProfile

About China Reform Management Performance

The success or failure of an entity such as China Reform Health often depends on how effective the management is. China Reform management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of China management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the China management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
China Reform is entity of China. It is traded as Stock on SHE exchange.
Please note, the presentation of China Reform's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, China Reform's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of China Reform's management manipulating its earnings.

China Reform Workforce Analysis

Traditionally, organizations such as China Reform use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare China Reform within its industry.

China Reform Manpower Efficiency

Return on China Reform Manpower

Revenue Per Employee232.5K
Revenue Per Executive30M
Net Loss Per Employee56.2K
Net Loss Per Executive7.3M
Working Capital Per Employee747.5K
Working Capital Per Executive96.5M

Complementary Tools for China Stock analysis

When running China Reform's price analysis, check to measure China Reform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Reform is operating at the current time. Most of China Reform's value examination focuses on studying past and present price action to predict the probability of China Reform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Reform's price. Additionally, you may evaluate how the addition of China Reform to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Money Managers
Screen money managers from public funds and ETFs managed around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency